Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Comparison of Tc-99m pyrophosphate and Tc-99m hydroxymethylene diphosphonate in acute myocardial infarction: concise communication

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5409836

A clinical comparison between a new bone seeking radiopharmaceutical, Tc-99m hydroxymethylene diphosphonate (TcHMDP) and the standard agent, Tc-99m pyrophosphate (TcPPi), was performed in 18 patients with acute myocardial infarction. Each patient was imaged initially with either TcHMDP or TcPPi, and imaged 24 h later with the other tracer. All 18 patients had images positive for acute myocardial infarction with TcPPi, whereas 16 or 18 patients (89%) had positive studies with TcHMDP. The TcPPi images were graded significantly superior to those obtained with TcHMDP in 61% of the patients, and they were equal in 33%. In only one patient (6%) was TcHMDP better. The results indicate that compared with TcHMDP, TcPPi not only has a superior sensitivity for acute myocardial infarction but also has a significantly increased intensity of uptake in positive areas. TcPPi remains the agent of choice for myocardial infarct imaging.

Research Organization:
Bowman Gray School of Medicine, Winston-Salem, NC
OSTI ID:
5409836
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 21:3; ISSN JNMEA
Country of Publication:
United States
Language:
English